At Takeda, we’re working on innovative science today that will shape the future of cancer care tomorrow. Teresa Bitetti and Phuong Khanh (PK) Morrow discuss our drive to support and bring hope to people impacted by cancer.
Takeda Oncology
Pharmaceutical Manufacturing
Cambridge, MA 169,259 followers
We aspire to cure cancer, with inspiration from patients and innovation from everywhere.
About us
Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. At Takeda, we are united by our aspiration to cure cancer. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in the lives of people living with cancer. Our research and development efforts are focused on advancing medicines for thoracic, gastrointestinal and hematologic cancers by leveraging modalities best suited to treat these diseases. Our in-house expertise and innovation are complemented by our valued partners. We fuel these relationships with respect, scientific rigor and a shared commitment to address the most urgent needs of patients. Our diverse global team fosters an inclusive environment where employees are welcomed, empowered, and inspired. We are committed to ensuring that patients globally can benefit from and access our portfolio of medicines, while also progressing a pipeline of potential treatments for the future. For more information, visit www.takedaoncology.com. If you are interested in learning more about current career opportunities, please visit the Takeda Pharmaceuticals Career Page. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/
- Website
-
http://www.takedaoncology.com
External link for Takeda Oncology
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
- Founded
- 1993
- Specialties
- oncology, drug development, and biotechnology
Locations
-
Primary
Get directions
40 Landsdowne St.
Cambridge, MA 02139, US
Employees at Takeda Oncology
Updates
-
We’re pleased to share that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation (BTD) for our investigational therapy with Protagonist Therapeutics for the treatment of erythrocytosis in patients with polycythemia vera (PV). Learn more: https://lnkd.in/gZZfmPnc
-
-
Our team’s drive to cure #cancer is fostered by curiosity. Inspired by a high school teacher, Minakshi Guha, our Liquid Biopsy Strategy Lead, embarked on a journey in #STEM that led to a career advancing patient care in #oncology. Learn more about our science: https://lnkd.in/gfQxmqjT
-
We believe that the patient voice is the cornerstone of effective cancer care and that collaboration is key to empowering shared treatment decision making. Together, with patients leading the way, we can make a real difference in oncology. Learn more from our President, Global Oncology Business Unit, Teresa Bitetti: https://lnkd.in/gBexZKKy
-
Minakshi Guha’s, main goal: standardizing biomarker testing in #oncology care. As our Liquid Biopsy Strategy Lead, hear her explain what ctDNA is and how it can impact the treatment experience for people living with #cancer. Learn more about our science: https://lnkd.in/gfQxmqjT
-
Our #TeamTakeda riders brought incredible energy to this year’s Pan-Mass Challenge, cycling for a cure and supporting vital cancer research. We’re proud of their dedication in helping advance treatments for people battling cancer. Please join us in recognizing their impact! #PMC2025 #CloserByTheMile #TeamTakeda
-
-
Meet Minakshi Guha, a scientist on #TeamTakeda who leads our liquid biopsy strategy. Minakshi breaks down the science behind liquid biopsy and its advantages over traditional tissue biopsy for people living with #cancer. Go deeper into our science: https://lnkd.in/gfQxmqjT
-
Living with metastatic colorectal cancer (#mCRC) is not one-size-fits-all. We remain committed to understanding the unique perspectives and unmet needs of the global mCRC community at every stage of their journey. Read the results of our Europe and Canada-based patient survey presented at #ESMOGI25: https://lnkd.in/guT46tNx
-
Following ALK Positive Awareness Month, we are thankful for the perspectives of patient advocates like Summer – a wife, mother and advocate living with ALK+ non-small cell #LungCancer. Read her advice on navigating a #cancer diagnosis and treatment. Discover available resources to help on your care journey by heading to https://lnkd.in/eqPvcyYn
-
-
Attending the ESMO - European Society for Medical Oncology Gastrointestinal Cancers Congress this year? Join us for a Takeda Oncology–sponsored medical symposium discussing the factors that influence treatment decisions for people living with metastatic colorectal cancer (#mCRC). View details on this Friday’s symposium here: https://lnkd.in/g9Wqz5iK We hope to see you there! #ESMOGI25
-